4
Changes in Ownership
Vera Therapeutics, Inc. Filed Acc 0001209191-22-052719
President and CEO sold 32,000 shares at an average $20.90 ($668,773)
- President and CEO acquired 32,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Fordyce Marshall · President and CEO
Table I: Non-derivative
10 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-10-03 | Exercise or conversion : show line 1 in the form | +11,369 | $2.90 | $32,934 | 192,519 | D |
| 2022-10-03 | Sale : show line 2 in the form | −11,369 | $20.39 | $231,757 | 181,150 | D |
| 2022-10-03 | Exercise or conversion : show line 3 in the form | +2,408 | $2.90 | $6,975 | 183,558 | D |
| 2022-10-03 | Sale : show line 4 in the form | −2,408 | $21.16 | $50,951 | 181,150 | D |
| 2022-10-04 | Exercise or conversion : show line 5 in the form | +6,899 | $2.90 | $19,985 | 188,049 | D |
| 2022-10-04 | Sale : show line 6 in the form | −6,899 | $20.29 | $139,971 | 181,150 | D |
| 2022-10-04 | Exercise or conversion : show line 7 in the form | +10,418 | $2.90 | $30,179 | 191,568 | D |
| 2022-10-04 | Sale : show line 8 in the form | −10,418 | $21.69 | $225,994 | 181,150 | D |
| 2022-10-04 | Exercise or conversion : show line 9 in the form | +906 | $2.90 | $2,625 | 182,056 | D |
| 2022-10-04 | Sale : show line 10 in the form | −906 | $22.19 | $20,101 | 181,150 | D |
| Open-market sales · 32,000 sh · avg $20.90 · $668,773 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-10-03 | Exercise or conversion : show line 11 in the form Stock Option (Right to Buy) | −13,777 | 965,435 | D |
| 2022-10-04 | Exercise or conversion : show line 12 in the form Stock Option (Right to Buy) | −18,223 | 947,212 | D |
Loading xslF345X03/doc4.xml…